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ABSTRACT 
 In external beam radiation therapy, it is imperative that the prescribed dose is 
administered to the correct location and in the correct amount.  Though several ex vivo 
methods of quality assurance are currently employed to achieve this goal, verifying that 
the correct dose is received within the patient in situ is impossible without the capability 
of measuring dose inside the patient.  Recently, a method of measuring dose delivered 
within the patient has been developed, an implantable MOSFET dosimeter.  This 
dosimeter is implanted within the patient and records the dose received.  Since the 
dosimeter is implanted in the patient, it could serve a dual function as a fiducial marker 
for image guided radiation therapy (IGRT) treatment if it could be modified to be visible 
on x-rays.  In this study, modifications to the MOSFET dosimeter were made to increase 
its visibility for IGRT treatment.  To test whether the modifications hindered the 
dosimeter’s ability to accurately measure and transmit dose information, the energy 
dependence, angular dependence and wireless read range of the modified dosimeter were 
measured and compared to unmodified dosimeters.  It was found that the modified 
dosimeter performed as well as the unmodified dosimeter while also being suitable for 
use as a fiducial marker for IGRT treatment. 
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INTRODUCTION 
 For patients receiving radiation therapy, accurate and consistent delivery of dose 
is of the utmost importance.  Several publications have directly linked the accuracy and 
consistency of daily dose delivery with tumor control probabilities (for example, Brahme 
1984, Bortfeld 2006).  Several methods are utilized in the practice of radiation therapy to 
ensure accurate and consistent daily dose delivery.  These methods include utilizing 
patient immobilization devices, creating reproducible setups and performing quality 
assurance measurements of the radiation treatment machines.  For disease sites where 
internal anatomy is expected to shift relative to external markers, image guided radiation 
therapy (IGRT) can be used in addition to the above techniques to further ensure a 
consistent setup.  In IGRT, an image of the area to be treated (in the case of this thesis, 
an x-ray) is acquired while the patient is on the treatment table in the proper setup 
position before beginning each treatment session.  One such image, a megavoltage (MV) 
portal image can be acquired by adding a detector to the gantry of the linear accelerator 
(linac) and using the linac itself as the x-ray source.  Since MV level x-rays are limited 
in their contrast, some choose to add a kilovoltage (kV) source and detector to the linac, 
which can be used to generate a kV image or a cone-beam computed tomography image 
(CBCT). Whatever types of images are acquired, they are compared to digitally 
reconstructed radiographs generated from the treatment plan and a shift is made to 
correct for any discrepancies in patient alignment.  However, the quality of the x-rays 
taken can hinder proper alignment.  When aligning to a soft-tissue structure that is 
difficult or impossible to see on an x-ray, a fiducial marker, typically a small piece of 
gold or other high-Z material is implanted in the patient to assist the radiation therapy 
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technician with alignment.  The high density of a gold marker makes it visible on even 
the relatively low-contrast MV images.   
 Through IGRT and reproducible patient setups, we can verify that the patient is 
set up consistently, but the dose received cannot be verified without a way to measure 
radiation within the patient.  Recently, a method of measuring dose within a patient has 
been developed.  The Dose Verification System (DVS; Sicel Technologies, Morrisville, 
NC) is a permanently implantable radiation dosimeter designed to be implanted in a 
patient near the treatment site and to measure the dose delivered.  This measurement is 
extremely valuable in ensuring that the treatment plan is being delivered as prescribed.  
Since, like a fiducial marker, the DVS dosimeter has to be implanted within the patient, 
it would be ideal to have the DVS dosimeter act as the fiducial marker.  If possible, this 
combination would save the patient an additional implantation and would allow the 
advantages of the Dose Verification System to be combined with the advantages of 
IGRT treatment.   
Unfortunately, the current design of the DVS dosimeter, though visible on kV 
images cannot be seen on an MV portal image.  In order to be visible on an MV image, 
the existing dosimeter would have to be modified, but the modification would have to be 
done in such a way as to not hinder the dosimeter’s measurement ability.  The 
investigation of how to modify the dosimeter, and the subsequent testing of the new 
modified dosimeter’s measurement characteristics and its suitability for IGRT treatments 
is the subject of this thesis.  
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BACKGROUND 
Dose Verification System 
The Dose Verification System (DVS; Sicel Technologies, Morrisville, NC) 
consists of a permanently implantable dosimeter (Figure 1) and a wireless reader (Figure 
2). The dose is measured using metal oxide semiconductor field effect transistors 
(MOSFETs) within the dosimeter.  The MOSFETs used in the DVS dosimeter have a 
sensitive volume of 0.3mm x 0.05mm and comprise only a small portion of the 
dosimeter.  The remainder of the dosimeter is composed of electronic circuitry and an 
antenna.  When a dosimeter is to be read, the wand portion of the reader generates an 
electromagnetic field.  This field powers the dosimeter via its antenna.   The electronic 
 
Figure 1 - The DVS dosimeter is 20mm in 
length and 2.1mm in diameter.  It contains 
two MOSFETs 1.3mm from the end of the 
dosimeter that measure dose.  Source: Sicel 
Technologies Product Info Sheet.  Used with 
permission. 
 
 
Figure 2 – The wireless dosimeter 
reader produces a wave that induces a 
current in the dosimeter and receives the 
dosimeter’s measurements. 
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circuitry then reads the MOSFETs and uses the antenna to relay this information back to 
the reader by modulating the incident field.   
  The original dosimeter designed by Sicel was 3mm in diameter and 25mm in 
length and contained a single MOSFET.  Since then, the dosimeter has been redesigned 
to be smaller and now contains two MOSFETs, whose results are averaged to improve 
accuracy.  The current dosimeter (Figure 1) manufactured by Sicel Technologies is 
2.1mm in diameter, 20mm in length and contains two MOSFETs.  This new smaller 
model was used for all data in this thesis.  Literature that was based upon the original 
model will be noted and commented on for perspective, but since all dosimeters used in 
this thesis were of the new 20mm length variety, comparisons in dosimeter 
characteristics between this thesis and previous publications will be limited to those 
publications involving the new 20mm dosimeter.    
MOSFET Dosimetry 
 A MOSFET, as the name states, is a transistor.  An oxide insulated gate electrode 
lies between two electric contacts called a source and a drain (Figure 3).  When the gate-
oxide has no voltage, no current 
can flow from the source to the 
drain.  When the gate-oxide is 
supplied with the necessary 
amount of voltage (commonly 
called the threshold voltage), the 
MOSFET “turns on” and allows 
current to flow between the source and the drain.   
 
Figure 3 - Ionizing Radiation increases positive charge 
in the gate-oxide layer changing the threshold voltage 
of the MOSFET 
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MOSFETs can be used to measure radiation because the threshold voltage 
necessary to allow current to flow between the source and the drain increases with 
increasing radiation exposure to the gate-oxide.  When radiation is incident upon the 
MOSFET, it ionizes particles in the gate-oxide separating electrons from molecules.  
The positively ionized molecule is commonly referred to as a “hole”, because an 
electron has left the molecule leaving a hole behind.  Since the electrons can move more 
freely than the holes, some holes become trapped in the gate-oxide.  These holes are 
positively charged and therefore increase the threshold voltage necessary to allow 
current to flow between the source and the drain.  The threshold voltage therefore 
increases as increasing amounts of ionizing radiation increase the number of holes 
trapped in the gate-oxide.  Since the MOSFET is permanently changed by exposure to 
radiation, it should be considered a cumulative dosimeter.  Converting the threshold 
voltage to dose therefore requires knowing not only the increase in threshold voltage 
after an exposure, but also the total amount of dose the dosimeter has received.  The 
relationship between voltage shift and dose for the MOSFETs used in the DVS 
dosimeters for this project is shown in Figure 4 as was measured by the dosimeter’s 
manufacturer (Scarantino 2004).  Since the relationship between voltage and dose is 
non-linear, the manufacturer supplies a calibration curve for each dosimeter that relates 
the threshold voltage shift to the accumulated dose. 
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MOSFET Fading Effect 
Over time, some of the holes in the gate-oxide can recombine with electrons 
reducing the threshold voltage shift necessary to power on the MOSFET.  This fading 
effect must be taken into account when using a MOSFET dosimeter.  To overcome this 
problem, the DVS system was designed to require a pre-irradiation and post-irradiation 
voltage measurement.  Since the time between pre- and post- readings is small, the 
manufacturer determined empirically that the fade effect would not hinder the accuracy 
of the dosimeter provided the pre- and post-dose measurements were taken within 30 
minutes of each other. 
Previous Work with the DVS Dosimeter (original 25mm dosimeter) 
 The initial study with the DVS dosimeter (original 25mm version) was 
performed in canines at North Carolina State University - College of Veterinary 
 
Figure 4 – Threshold Voltage shift versus Accumulated Dose as measured 
by Scarantino (2004).  Used with Permission. 
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Medicine (Scarantino 2004).  The publication also reported characteristics of the 
dosimeter as tested in a phantom and water tank.  The dosimeter was noted to have a 
temperature dependence of “as much as 8 – 20 cGy per degree C (greater variation with 
more accumulated dose)” (Scarantino 2004).  When implanted in a patient, this 
temperature dependence would be a small source of error, if any, since body temperature 
is fairly consistent (demonstrated in the paper by placing the canines outside in the cold 
for 30 minutes and then re-testing showing no change for a 2.5cm deep dosimeter, but a 
dosimeter between 0.5 and 1.0cm deep showed a slight variation).  This temperature 
dependence is, however, a significant issue for in vitro testing, requiring that the DVS 
dosimeters be temperature controlled in all phantoms and water tanks.  The energy 
dependence of the dosimeter was performed at “6 and 18 MeV [sic]” and found to be 
less than 1.0% (Scarantino 2004).  The rotational angular dependence of the dosimeter 
(i.e. the beam is perpendicular to the long cylindrical axis of the dosimeter and the 
dosimeter is rotated so that the beam is hitting different sides of the MOSFETs in the 
dosimeter) was found to be ±1.3%.  The longitudinal angular dependence of the 
dosimeter (i.e. the beam is rotated along the long cylindrical axis of the dosimeter so 
that, for example, at a 270˚ rotation, the beam passes through the antenna and circuitry 
before hitting the MOSFET) was not reported and instead it was stated that beams 
parallel to the cylinder axis would be problematic and therefore surgeons had been 
instructed to implant the dosimeter so that it would be parallel to the body’s axis.  The 
fade of the dosimeter was reported as <2% over 20 minutes.  The precision of the 
dosimeter was reported as 3.5cGy due to using a 12-bit analog-to-digital converter.  The 
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author stated that the new dosimeter would have a 14-bit converter increasing the 
precision of the dosimeter to 0.8cGy (Scarantino 2004). 
A pilot study to test the safety and utility of the dosimeter (original 25mm 
dosimeter) was performed at Rex Healthcare (Raleigh, NC) and Duke University School 
of Medicine (Durham, NC) with implantation in “3 patients with lung cancer, 3 patients 
with prostate cancer, 3 patients with rectal cancer, and 1 patient with a sarcoma in the 
lower extremity” (Scarantino 2005).  The dosimeter characteristics section focused on 
the angular dependence of the dosimeter and stated that extensive testing of the dose 
isotropy had been performed on the longitudinal axis and had found that “the results 
hold as long as the angle of incidence is more than 30 degrees from the axis of the 
device” (Scarantino 2005).  If we define 270˚ as a beam which would go through the 
antenna and circuitry of the dosimeter before reaching the MOSFET, 0˚ as a beam 
perpendicular to the cylindrical axis and 90˚ as a beam which would go perpendicularly 
through the MOSFET side of the dosimeter first, then the authors appear to be stating 
that the longitudinal angular dependence of the dosimeter is not an issue between 300˚ 
and 60˚.  It is unclear what “the results hold” means in terms of an error value, but the 
author states that combining all of the errors gives the dosimeter an absolute accuracy 
value of 3.5% (1 standard deviation).   
Three additional papers were published testing the original 25mm dosimeter, all 
three focusing primarily on the reproducibility of readings (Beddar 2005, Briere 2005, 
Black 2005).  The first, performed at this institution (The University of Texas MD 
Anderson Cancer Center, Houston, TX), used a Cobalt-60 unit to test the reproducibility 
of the MOSFET threshold voltage and found a dose reproducibility within 5% or better, 
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2% or better with a better temperature controlled environment (Beddar 2005).  The 
second publication, also performed at this institution, tested the reproducibility of the 
dosimeter dose reading, which takes into account the reproducibility of not only the 
MOSFET threshold voltage shift, but also how well the manufacturer’s calibration curve 
related the voltage shift to an accurate dose value (Briere 2005).  The dose per fraction 
was varied from 100cGy/Fx to 400cGy/Fx and it was found that reproducibility varied 
from a standard deviation of 3.6% for the 100cGy/Fx reading to roughly 2% for the 200 
and 400cGy/Fx readings (Briere 2005).  The third publication combined an in vitro study 
of the dosimeter in a phantom with an in vivo study of the dosimeter implanted in 18 
patients and found that in vitro errors within ±5% are achievable, but that in vivo 
measurements frequently exceeded these levels (Black 2005). 
Two additional papers using the original DVS dosimeter were published, both 
reporting strictly in vivo results (Beyer 2007, Scarantino 2008).  The dosimeters were 
clinically tested in prostate (Beyer 2007) and breast and prostate (Scarantino 2008) 
disease sites.  Both papers found that the doses could vary significantly from planned.  
Both Beyer and Scarantino mention in the introduction that a new smaller version of the 
DVS dosimeter is now available.  Also, in the conclusions both papers suggest that the 
marker could be used for IGRT treatments since it is “visible in kV, CT, and ultrasound 
images” (Beyer 2007).   
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Previous Work with the DVS Dosimeter (new 20mm dosimeter) 
The first paper evaluating the new smaller dosimeter design tested the dose per 
fraction and rotational angular dependence (Briere 2007).  Briere et al. used the 
manufacturer’s dose 
calibration curve to record 
readings at rotational angles 
of 0, 45, 90, 135, 180 and 
225.  Two dosimeters per 
angle were used and each 
reading was repeated three 
times.  The results are shown in Figure 5.  The results are relative to the dosimeter’s 
mean value and “[do] not vary by more than 1.2%” (Briere 2007).   
A more complete characterization of the DVS dosimeter was published by Beyer 
et al. and included information on the dosimeter’s energy dependence as well as angular 
dependence in both the rotational and longitudinal directions (Beyer 2008).   Beyer et al. 
found that 15MV photons read 0.5% higher than 6MV photons.  The angular 
dependence results are shown in Figure 6.  
 
Figure 5 - Briere et al.'s measurement of rotational 
angular dependence (Briere 2007).  Used with 
Permission. 
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Figure 6 - Beyer et al.'s measurement of rotational (a) and longitudinal (b) angular 
dependence.  Used with permission (Beyer 2008).  Copyright 2008 IEEE. 
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DVS Dosimeter (new 20mm dosimeter) in other radiotherapy treatment modalities 
  The DVS dosimeter has also been tested in brachytherapy (Fagerstrom 2008) 
and with a Cyberknife® system (Accuray Inc., Sunnyvale, CA) (Scalchi 2010).  The 
Cyberknife® paper verified that the DVS dosimeter could be used in Cyberknife® 
treatment without additional corrections (Scalchi 2010).  No characteristics relevant to 
this work were investigated. 
The brachytherapy paper found a “clear difference in detector sensitivity… for 
60Co and 192Ir energies”, which could not be linearly corrected for (Fagerstrom 2008).  
This paper also tested the rotational angular dependence and found an average variation 
of “less than 1.5% for each angle, showing little dosimeter dependence on incident 
rotational angle” (Figure 7) (Fagerstrom 2008).  Fagerstrom et al. also tested the 
longitudinal angular dependence (Figure 8) and found a -16% angular dependence 
through the antenna coil for the 192Ir.  It is important to note that this paper ignored the 
previously established angle definitions in favor of a completely opposite definition.  
Therefore, 90o is through the antenna coil, whereas all other papers including this thesis, 
define 270o as through the antenna coil. 
13 
 
Figure 8 - Fagerstrom et al.'s longitudinal angular dependence 
(Fagerstrom 2008).  Used with Permission. 
 
Figure 7 - Fagerstrom et al.'s rotational angular dependence 
results (Fagerstrom 2008) 
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Using the DVS dosimeter as a fiducial marker 
 After much speculation that the DVS dosimeter could be used as a fiducial 
marker, one paper tested the assumption (Kry 2009).  Of course, since the commercially 
available dosimeter can only be seen with kV-level imaging, a kV imager was used.  Kry 
et al. found that the detectors were easily visualized at kV levels and that displacements 
were recognized by the localization software to within 0.1cm (Kry 2009). 
  
15 
METHODS AND MATERIALS 
Prototype Dosimeters 
 The manufacturer, Sicel Technologies, had several ideas for incorporating a gold 
marker into their design.  Therefore, it was necessary to test some different methods 
before deciding on a design 
with which to test the 
dosimetry.  The 
manufacturer proposed 
adding a gold sleeve to the 
antenna part of the dosimeter 
(Figure 9B), adding solid 
gold to both ends of the 
dosimeter (not shown), or 
adding gold wire to wrap 
around the antenna assembly 
(Figure 9C).  After 
attempting fabrication, the 
company determined that 
redesigning the dosimeter in 
order to add a marker to both 
sides was infeasible.  It 
therefore abandoned the dual-marker design and sent only the gold wire and gold sleeve 
design.    
 
Figure 9 - Prototype Dosimeters Standard (A) Gold 
Sleeve (B) and Wire Wrapped (C) 
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Imaging – Prototype Visualization Study 
These prototypes, along with a commercially available dosimeter, clinically used 
0.8mm x 3.0mm and 1.2mm x 3.0mm 
cylinder gold markers (CIVCO Medical 
Solutions, Kalona, IA) and a prototype made 
by Dr. Salehpour (one of the old 25mm 
dosimeters, broken open and with gold 
melted on the inside of one end) were 
imaged in a Rando anthropomorphic 
phantom (The Phantom Laboratory, Salem, 
NY) as shown in Figure 10.  The phantom 
and fiducials were imaged using the On Board Imager® (OBI; Varian Medical Systems, 
Palo Alto, CA) on a linear accelerator (linac) clinically used for IGRT treatment.    
Anteroposterior (AP) and lateral images were taken at both MV and kV levels.  Also, 
cone beam CT (CBCT) was taken using the OBI.  Clinically used imaging techniques 
were used including 2MU for the AP MV image, 5MU for the lateral MV image, 84kVp, 
10 mAs for the AP kV image and 105kVp, 80mAs for the lateral kV image.  Since this 
was a preliminary study, all markers were placed in the phantom at the same time to 
avoid the considerable time needed to open the phantom, replace a fiducial marker, set 
up and re-image.  Therefore, after deciding upon a dosimeter design, the imaging part 
was repeated under more controlled conditions.  To provide a quantifiable visualization 
measurement, the difference in pixel value between the dosimeters and a nearby 
background was calculated on the MV AP image.  The difference was calculated with a 
 
Figure 10 - Pelvic section of Rando 
phantom used for preliminary imaging 
study 
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freely available DICOM image viewer (ImageJ v1.43, U.S. National Institute of Health, 
Bethesda, MD).  To calculate the difference, the mean pixel value of a region of interest 
(ROI) contained within the marker part of each dosimeter was compared to an ROI of 
the same size outside, but close to each dosimeter.  The mean pixel value of the 
background ROI was subtracted from the mean pixel value of the marker to determine 
the mean pixel value difference between the two. 
Modified Dosimeter 
 Based upon the preliminary study, the wire-wrapped dosimeter design was 
chosen (see Results & Discussion 
section).  The modified dosimeter 
(Figure 11) is slightly longer than the 
commercially available dosimeter since 
fabrication of the modified dosimeter 
required re-sealing of the commercially 
available dosimeter.   The additional 
length also made it impossible for the 
modified dosimeter to fit into the 
manufacturer’s calibration apparatus, 
which is used to form the calibration curve necessary to convert the threshold voltage 
shift of the MOSFETs into a dose value.  Therefore, acquisition of the data required a 
“self-calibration” method as described later in the “Data Acquisition – Compensating for 
the Calibration Curve” section. 
  
 
Figure 11 - Modified dosimeter (far left) in 
comparison with the current commercially 
available dosimeter.  U.S. dime included for 
size comparison. 
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Imaging – Controlled Study 
 After choosing to proceed with the wire-wrapped model dosimeter, the imaging 
part of the study was repeated placing each item to be imaged at the same position in the 
phantom.  Since the provided wire-
wrapped models varied slightly from 
the first provided prototype, the new 
model was used for this imaging study.  
The Rando anthropomorphic phantom 
was again used (Figure 12), adding the 
compression device in an attempt to 
reduce streaking artifacts between the 
slices.  The commercial dosimeter, modified dosimeter (wire wrapped model), a 
clinically used 0.8mm x 3.0mm cylinder gold fiducial marker (CIVCO Medical 
Solutions, Kalona, IA) and a clinically used carbon dumbbell fiducial marker (Carbon 
Medical Technologies, St.Paul, MN) were imaged one at a time in the same location.  
The location was chosen to be near the pubic symphysis of the Rando phantom since the 
dosimeters have been clinically tested for prostate disease sites and since IGRT is 
commonly used in the treatment of prostate cancer.   
 A line profile of the dosimeters and markers showing pixel value versus position 
was created in a freely available DICOM image viewer (ImageJ v1.43, U.S. National 
Institute of Health, Bethesda, MD).  The line profiles were used as a quantifiable way of 
assessing visibility.  
 
Figure 12 - Pelvic section of Rando 
phantom used for controlled imaging study 
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Wireless Reader 
 The dosimeters are read with a wireless reader supplied by the manufacturer 
(Figure 2).  This reader consists of a wand and base computer system. This computer 
system is networked to an institution’s 
database.  Patients are loaded into the 
database and the dosimeters assigned to 
each patient, as well as the predicted dose 
to each dosimeter, are recorded.  The 
dosimeters are assigned to each patient 
using a manufacturer-supplied bar code 
(Figure 13).  This bar code contains the 
dosimeter identification information and 
supplies the coefficients of the calibration 
curve needed to convert the dosimeter’s 
voltage reading into a dose.  When a 
dosimeter needs to be read, the patient to 
be read is selected using the reader’s base display.  Then, the wand is placed near the 
patient and a high voltage supply generates an electromagnetic wave.  This wave powers 
the dosimeters through their antenna.  As the dosimeter is powered, it uses the antenna to 
modulate the incident electromagnetic wave, which sends back the threshold voltage 
read on each of the two MOSFETs.  The wand acts as both transmitter and receiver of 
the electromagnetic waves.  The reader’s base station converts the threshold voltage read 
by the MOSFETs into a dose value using the manufacturer’s supplied calibration curve. 
 
Figure 13 - Bar Code Reader (top) and 
sample bar code (bottom) 
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Data Acquisition – Compensating for the Calibration Curve 
 As mentioned earlier, the modified dosimeters were too long to be calibrated by 
the manufacturer, as the commercially available dosimeters would be.  In order to relate 
the threshold voltage shift in the MOSFETs to a known dose, it was necessary to acquire 
the data in a certain fashion so that our own calibration curve could be created.  The 
procedure described below was suggested by the manufacturer, Sicel Technologies, and 
had been used for studies performed by the manufacturer and in previous publications 
with the dosimeter (e.g. Beyer 2008).  The procedure involves taken a known reference 
value in between each desired measurement.  Then, a linear fit (which acts as the 
calibration curve) is applied to the reference values and the measured values are 
compared to their expected position on this line.  For example, in the rotational angular 
dependence tests, 0˚ was chosen as the reference value.  Data were taken in the order 0˚, 
40˚, 0˚, 80˚, 0˚, etc.   This analysis is shown graphically in Figure 14.   
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 One major advantage of this procedure is that multiple measurements can be 
taken in a single session, rather than separating measurements by 24 hours.  (If using the 
calibration curve, readings must be separated since the curve assumes a clinical 
treatment schedule and therefore compensates for the fading effect that would occur over 
the typical 24-hour period between irradiation fractions.)  To ensure the accuracy of this 
procedure, data were taken under strict time controls.  A stopwatch was used to measure 
that the time between pre- and post- irradiation readings, time between measurements, 
and time of irradiation were the same for the entire series of a test procedure.  These 
controls were necessary to ensure that the time-dependent fading effect did not add any 
uncertainty into the data.   
 
Figure 14 - Sample data analaysis.  Fractions 1,3,5 represent reference value of 
0˚.  Fractions 2,4 represent test values in the rotational angular study of 40˚, 
80˚, respectively. 
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Read Range Study 
 There was concern upon modifying the dosimeters that the depth at which they 
would be able to be read might be compromised.  A dosimeter that is unable to be read is 
useless.  Therefore, the read range 
of both the commercial and 
modified dosimeters was tested for 
comparison.  Three dosimeters 
were placed in a holder designed 
for use in the energy dependence 
study (Figure 15).  This holder was 
placed inside a water tank with the 
wireless reader placed as close as possible to the side of the tank.  The distance of the 
dosimeters from the reader was measured using a measuring tape and the distance was 
increased by 1cm until the reader was no longer able to read the voltage from one or 
more of the three dosimeters.  The greatest distance at which all three dosimeters could 
be read was recorded as the read range. 
  
 
Figure 15 - Dosimeter holder with three DVS 
dosimeters.   
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Energy Dependence Study 
 The energy dependence of the dosimeters at 6MV and 15MV photon energies 
was investigated using a water-tank 
(Figure 17) of the type typically 
used for Task Group 51 calculations 
(TG51; Almond 1999).  Since the 
MOSFETs have some temperature 
dependence which, though not an 
issue in the temperature regulated 
body, can be an issue in in vitro 
testing, the water was temperature 
controlled to 37˚ C and a small 
circulating pump was placed in the 
tank to ensure that the heated 
water was evenly distributed 
throughout the tank.  A 
Farmer-type ion chamber 
(PTW 30013; PTW-New 
York Corporation, 
Hicksville, NY) was placed 
in a depth-control apparatus 
in the water tank.  The depth 
of the ion chamber was 
 
Figure 16 - Dosimeter holder in water tank. The tube 
end of the dosimeter holder is the same size as the 
ionization chamber used in the tank allowing the 
MOSFET readings to be compared with absolute 
dose measurements. 
 
 
Figure 17 – The water tank is shown with 
heater apparatus and circulating pump. 
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adjusted for each energy until dmax was found.  The exposure at this depth was converted 
into absolute dose according to TG51 protocol.  A custom designed holder was 
manufactured to hold three DVS dosimeters in the same apparatus as the ion chamber 
(Figure 15, Figure 16).  The center dosimeter was placed in the center of the beam with a 
dosimeter 1cm away on either side.  After using the ion chamber to find dmax and 
calculate the dose at that point (dmax includes the adjustment for the active volume of the 
ion chamber by shifting by 0.6 rcav according to TG-51 protocol), the ion chamber was 
removed and replaced with this apparatus.  Readings for 6MV and 15MV photon 
energies were taken at their respective dmax’s.  The procedure was repeated three times 
with three dosimeters each time for a total of nine readings.  6MV photons were chosen 
as the reference value.  The readings from the dosimeters were corrected for any 
difference in the expected dose as calculated by the ion chamber.  Both the modified and 
commercial dosimeters were tested with this procedure for comparison. 
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Angular Dependence Temperature Control Apparatus 
 As mentioned previously, since the MOSFETs are temperature sensitive, it was 
necessary to control the 
temperature of the 
dosimeters for in vitro 
testing.  This was 
accomplished using 
tubing connected to a 
tank of heated water 
(Figure 18).  A small 
pump circulates the 
water through a series 
of tubing which runs 
through the angular dependence phantom.  A thermistor on the tubing is connected to a 
controller (CN9500 CSC32, Omega Engineering, Inc., Stamford, CT), which powers on 
an aquarium heater.  The controller was set to heat the water to 37˚ C.  The temperature 
was verified using independent thermistors connected to an electronic thermometer 
(800023, Sper Scientific, Scottsdale, AZ).  
 
Figure 18 – Temperature controlled water supply flowed 
through all phantoms used in this study to keep the 
MOSFETs at 37˚ C. 
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Angle Definition 
 
 The angular dependence of the dosimeter from a wide range of angles was tested.  
To aid in understanding this data, it is important to define the angles in various planes.  
As is shown in Figure 19, rotational angles are defined as angles around the short axis of 
the dosimeter.  The longitudinal angles are angles across the long axis of the dosimeter 
at a 0˚ rotation.  All longitudinal angles are therefore incident on the back of the circuitry 
substrate.  Azimuthal angles are longitudinal angles at a 90˚ rotation.  Azimuthal angles 
are therefore incident on the side of the circuitry substrate. 
  
 
Figure 19 - Angle Definition 
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Angular Dependence Study 
 The angular dependence study was performed in a custom designed spherical 
phantom.  The phantom holds one dosimeter at the center of the sphere, enabling beams 
from a wide range of angles to 
pass through the same amount 
of material before being 
incident on the dosimeter.  The 
insert within the phantom 
allows the dosimeter to be 
rotated through various 
rotational angles.  The insert is 
also fitted with tubing apparatus 
to enable heated water to flow 
through the phantom, ensuring 
that the dosimeter is kept at a 
constant temperature.  A CT 
scan of the phantom was 
obtained (GE Lightspeed16; GE 
Healthcare, Waukesha, WI) and 
the dose from beams at different 
gantry angles was calculated 
using a treatment planning 
system (Pinnacle v8.0m, Philips 
 
 
Figure 20 - Spherical Phantom (top) close-up of 
insert (middle; dosimeter identified with dashed 
circle) and close-up of side of phantom showing 
how insert can be rotated (bottom) 
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Healthcare, Andover, MA).  Based upon the dose calculations of the treatment planning 
system, it was found that beams incident in the longitudinal direction on to the dosimeter 
from 290˚ - 70˚ resulted in doses to the sensitive part of the dosimeter to within 0.5% of 
each other.  Longitudinal angles more extreme than this began to be attenuated by the 
tubing and holder apparatus and therefore resulted in lower doses than the other angles.  
The study was therefore limited to longitudinal angles between 290˚ and 70˚.  The 
longitudinal angles 290˚, 310˚, 330˚, 350˚, 0˚, 10˚, 30˚, 50˚, and 70˚ were chosen to be 
measured.  For the rotational direction, it was desired that angles from all directions be 
taken so angles at every 40˚ were chosen.  It was also desired to compare these results to 
previously published work, so angles at 90˚, 180˚ and 270˚ were also chosen.  The 
rotational angles tested were therefore 0˚, 40˚, 80˚, 90˚, 120˚, 160˚, 180˚, 200˚, 240˚, 
270˚, 280˚ and 320˚.  After discovering that the 90˚ rotational angle under responded 
when compared to the 0˚ angle, it was decided to also test the longitudinal dependence 
of the dosimeter when it had been rotated 90˚ (i.e. the radiation beam is incident on the 
side of the circuitry board) to see how it compared to the longitudinal dependence at 0˚ 
(i.e. the radiation beam is incident on the face of the circuitry board).   This so-called 
“azimuthal” dependence was tested at the same angles as the longitudinal dependence of 
290˚, 310˚, 330˚, 350˚, 0˚, 10˚, 30˚, 50˚, and 70˚.  Since no data had been published that 
covered such a comprehensive set of angles, it was necessary to perform the procedure 
on both the modified and commercial dosimeters for comparison.  Each angle was tested 
with three different dosimeters of each type.    
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RESULTS AND DISCUSSION 
Imaging – Prototype Visualization Study 
 The images acquired for this study are shown in the figures below.  The 
dosimeters are labeled according to the legend in Table 1, which also shows the contrast 
between the imaged marker or dosimeter and a nearby background in terms of pixel 
difference.  The kV AP view of the dosimeters is shown in Figure 21.  The MV AP view 
is shown in Figure 22.  The kV lateral view is shown in Figure 23.  The MV lateral view 
is shown in Figure 24.  The CBCT slices are shown in Figure 25. 
 
 
Table 1 - Legend for Prototype Visualization Images and Average Pixel 
Difference from Background on MV AP image 
 
30 
 
 
Figure 21 - kV AP View of Prototype Visualization Study.  From top left to bottom 
right: E (1.2mm Gold Marker), D (25mm Dosimeter with Marker), F (0.8mm Gold 
Marker), B (Gold Sleeve Modified Dosimeter), A (Standard Dosimeter), C (Wire 
Wrapped Modified Dosimeter) 
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Figure 22 - MV AP View of Prototype Visualization Study. From top left to bottom 
right: E (1.2mm Gold Marker), D (25mm Dosimeter with Marker), F (0.8mm Gold 
Marker), B (Gold Sleeve Modified Dosimeter), A (Standard Dosimeter),C (Wire 
Wrapped Modified Dosimeter) 
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Figure 23 - kV Lateral View of Prototype Visualization Study. From top left to 
bottom right: D (25mm Dosimeter with Marker), E (1.2mm Gold Marker), F (0.8mm 
Gold Marker), A (Standard Dosimeter), B (Gold Sleeve Modified Dosimeter), C 
(Wire Wrapped Modified Dosimeter) 
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Figure 24 - MV Lateral View of Prototype Visualization Study. From left to right: F 
(0.8mm Gold Marker), E (1.2mm Gold Marker), D (25mm Dosimeter with Marker).  
Markers A – C unviewable due to streak 
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Figure 25 - CBCT Slice of Prototype Visualization Study.  Top Image left to right: E 
(1.2mm Gold Marker), D (25mm Dosimeter with Marker), F (0.8mm Gold Marker).  
Bottom Image left to right: B (Gold Sleeve Modified Dosimeter), A (Standard 
Dosimeter), C (Wire Wrapped Modified Dosimeter)  
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All six tested markers were visible on the kV AP and lateral images and the 
CBCT, as expected.  The MV lateral image (Figure 24) had a streak artifact obscuring 
markers A, B and C however, the MV AP image (Figure 22) shows that all markers, 
with the exception of the standard dosimeter, are visible.  The standard dosimeter had 
the lowest difference from background of only 5, making it very difficult to see. The 
modified dosimeter prototypes were similar in visibility to the commercially available 
fiducial markers, although the artifacts on the CBCT were significantly higher for the 
modified dosimeters than for the markers.  The artifacts from the modified dosimeters 
seemed similar to the commercially available dosimeter with the gold sleeve modified 
dosimeter possibly having more artifacts.  The results of this study were reported to the 
manufacturer.  Since both modified dosimeter prototypes were visible on the MV AP 
image, the next step was to determine the prototype with which to proceed.  After some 
discussion with the manufacturer, it was discovered that the gold sleeve modified 
dosimeter caused a significant hindrance in the wireless read range of the dosimeter.  
The gold sleeve induced eddy currents in the antenna assembly, which, in the 
manufacturer’s read range test, reduced the wireless read range from 15cm to 9cm.  
Therefore, the decision was made to proceed with the wire-wrapped design for 
dosimetry testing.   
Imaging – Controlled Study 
 Ten wire-wrapped model modified dosimeters were provided for the dosimetry 
studies.  These dosimeters were more carefully manufactured than the prototypes and so 
were slightly different from the wire-wrapped prototype imaged in the preliminary 
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study.  In addition, the preliminary study did not equally compare the dosimeters since 
they were all done at a different location in the phantom.  Therefore, new images were 
taken under more controlled conditions and using the same modified dosimeter as would 
be used for all of the dosimetry tests.  The commercial dosimeter, wire-wrapped 
modified dosimeter, 0.8mm x 3.0mm gold marker, and carbon dumbbell marker were 
imaged. The kV AP images are shown in Figure 26.  The MV AP images are shown in 
Figure 27 and a closer view of these images is provided in Figure 28.  The kV lateral 
images are shown in Figure 29 and the MV lateral images are shown in Figure 30.  The 
CBCT slices are shown in Figure 31 and Figure 32.  Line profiles to provide a 
quanititative assessment of visualization are shown in Figure 33 and Figure 34. 
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Figure 26 - kV AP images.  From top left to bottom right: Commercially 
Available Dosimeter, Modified Dosimeter, Gold Marker, Carbon Marker 
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Figure 27 - MV AP images.  From top left to bottom right: Commercially Available 
Dosimeter, Modified Dosimeter, Gold Marker, Carbon Marker 
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Figure 28 - MV AP images Magnified.  From top to bottom: Commercially Available 
Dosimeter, Modified Dosimeter, Gold Marker, Carbon Marker 
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Figure 29 - kV Lateral images. From top to bottom: Commercially Available 
Dosimeter, Modified Dosimeter, Gold Marker, Carbon Marker 
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Figure 30 - MV Lateral images. From top left to bottom right: Commercially 
Available Dosimeter, Modified Dosimeter, Gold Marker, Carbon Marker 
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Figure 31 - CBCT Slice of Commercial Dosimeter (top), Modified Dosimeter (bottom) 
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Figure 32 - CBCT Slice of Gold Marker (top), Carbon Marker (bottom) 
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Figure 33 - Line profiles of the AP images.  The gold marker and modified 
dosimeter show comparable results. 
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Figure 34 - Line profiles of the lateral images.  The gold marker and modified 
dosimeter show comparable results. 
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 All markers show good visibility in kV AP images (Figure 26).  On the kV 
lateral images (Figure 29), the carbon marker cannot be seen.  On the MV AP images 
(Figure 27), the gold marker and modified dosimeter can be clearly seen, though the 
modified dosimeter is easier to find due to it being much larger than the gold marker.  A 
shadow of the commercial dosimeter is barely visible and the carbon marker is not 
visible.  On the MV lateral images (Figure 30), the markers are harder to find, but only 
the carbon marker is completely impossible to see.  The gold marker and modified 
dosimeter are considerably easier to see than the commercial dosimeter, of which only a 
shadow is visible.  On the CBCT images (Figure 31 and Figure 32), the modified 
dosimeter shows the largest star artifact with the carbon marker showing almost none.   
 The line profiles (Figure 33 and Figure 34) show that the modified dosimeter and 
gold marker behave comparably for all imaging types.  The relative pixel difference of 
the modified dosimeter and gold marker are similar, but the modified dosimeter has a 
larger area of difference, further increasing its visibility.  Though the carbon marker and 
commercial dosimeter underperform the gold marker and modified dosimeter on the 
imaging tests, the line profiles on the kV images show pixel differences that would still 
clearly be visible.  
 Based upon these results, the modified dosimeter can be used as a fiducial 
marker for both kV and MV imaging applications.  In the MV images, the gold fiducial 
marker has a greater contrast difference from background than the modified dosimeter; 
however, the modified dosimeter’s larger size makes it more easily viewable.  The CT 
artifacts are concerning, however the commercially available dosimeter also shows such 
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artifacts, so the increase in them via modification should not significantly affect their 
use.   
Read Range Study 
 It was found that the read range of both the commercial and modified dosimeters 
was 9 cm.  At 10 cm, the dosimeters were detected, but could not be read.  Beyond 10 
cm, the dosimeters were not even detected by the wand apparatus.  This result 
demonstrates that the modification did not affect the depth at which the dosimeters could 
be read.  It was a little concerning, however, in that the manufacturer had stated that the 
dosimeters had a 15 cm read range.  The manufacturer was contacted about this 
discrepancy and it was discovered that their read range tests used a new model of 
wireless wand.  This new model produces an electromagnetic wave with higher 
amplitude, and is more sensitive in its read response.  The manufacturer stated that the 
new model wand extended the range of the dosimeters by roughly 4 cm, bringing the 
results of this work closer to the manufacturer’s stated values. 
Energy Dependence Study 
The results of the energy dependence study are shown in Table 2.  There is a 
small variation between the energy response at 6MV and 15MV.  Beyer et al. (2008) 
found that 15MV responded 0.5% higher than 6MV for the commercial dosimeter, 
consistent with the results of this study.  
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The modified dosimeter responds differently to 15MV than the commercial 
dosimeter, under responding by -1.43% instead of over-responding by 0.67%.  This 
difference is statistically significant (p=0.0136), but it is not believed to result from any 
modification of the dosimeter.  Each batch of MOSFETs has specific energy dependence 
characteristics.  Sometimes the dosimeters over respond to higher energies, sometimes 
they under respond.  According to the manufacturer, typical values are ±1%.  The 
MOSFETs used to create the modified dosimeter probably had different intrinsic energy 
dependence than the MOSFETs used to create the commercial dosimeters.  However, 
even if the difference is caused by the dosimeter modification, the resulting energy 
dependence is still not clinically significant.  The dosimeters are guaranteed by the 
manufacturer to be within ±5%.  The dosimeters are calibrated to split the difference 
between high and low energy photons, so if used for 6MV photons, the modified 
dosimeters would read 1.43%/2 = 0.72% and if used for 15MV photons, they would read 
-0.72%.  This error, combined with the 2% inherent uncertainty in readings, still places 
the dosimeter’s characteristics well within the ±5% specified range. 
  
 
Table 2 - Results of the Energy Dependence Study for both the commercial 
and modified dosimeter 
 
Energy n Commercial Dosimeter Modified Dosimeter p-value
6MV 9 0.00% 0.00%
15MV 9 0.67% -1.43% 0.0136
Table 2 - Energy Dependence Study
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Rotational Angular Dependence Study 
 The rotational angular dependence of the dosimeter is reported in Table 3 and 
graphically in Figure 35. 
 
 
Table 3 - Rotational Angular Dependence of both the Commercial and Modified 
Dosimeters 
 
Rotational Angle n Commercial Dosimeter Modified Dosimeter p-value
0 3 0.00% 0.00%
40 3 -0.22% -0.48% 0.843
80 3 -2.98% -4.57% 0.302
90 3 -3.93% -4.91% 0.485
120 3 -2.01% -1.85% 0.902
160 3 -0.07% 0.41% 0.718
180 3 1.75% 1.37% 0.773
200 3 1.61% -0.63% 0.192
240 3 -1.34% -0.93% 0.756
270 3 0.37% -1.00% 0.357
280 3 -0.25% -1.79% 0.314
320 3 2.32% -0.19% 0.162
Table 3 - Rotational Angular Dependence
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 The dosimeters are largely in agreement with each other, with the greatest 
variation occurring at 200˚ and 320˚, which show a difference of 2.24% and 2.51%, 
respectively.  These differences are not statistically significant (p=0.192 and p=0.162, 
respectively).  In terms of the actual readings by the dosimeters, rotational angular 
response is generally within ±2%, with the exception of 90˚, which reads -3.93% for the 
commercial and -4.91% for the modified.  The dosimeters are known to under-respond 
 
Figure 35 - Rotational Angular Dependence 
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in this direction, though this study found higher variation than had been previously 
reported (-2.5% (Beyer 2008) and -1.2% (Briere 2007)).  This result is a little concerning 
since a systematic -4.91% error could cause readings to exceed the manufacturer’s 
specified ±5% guarantee.  However, as with the energy dependence, the dosimeters are 
calibrated to split the difference between the 0˚ and 90˚ reading, so that a 90˚ beam 
would actually read as -4.91%/2 = -2.45%.  Also, typical radiation therapy treatments are 
given with a wide range of beams from multiple angles.  Since 90˚ is the only angle that 
under responds so much, beams incident at other angles would serve to average out the 
under response from 90˚.  Though the dosimeter’s intrinsic characteristics are 
interesting, the focus of this study is in determining how the modification of the 
dosimeter affected its dosimetry characteristics.  This test showed that the modification 
of the dosimeter did not alter its rotational angular dosimeter characteristics. 
  It is unexpected that the 90˚ and 270˚ rotations are not in greater agreement.  It is 
possible that the MOSFETs are soldered on to the circuitry at this angle, which is why 
the attenuation is seen here and at no other angle. 
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Longitudinal Angular Dependence Study 
 The longitudinal angular dependence of both the commercial and modified 
dosimeters is shown in Table 4. 
 
 The longitudinal angular responses are largely in agreement, with the greatest 
discrepancy occurring at 350˚.  At 350˚, the commercial dosimeter under-responds by -
1.81% compared to 0˚ and the modified dosimeter over-responds by 1.55%.  The 
difference is not statistically significant (p=0.101) and it seems unlikely that modifying 
the dosimeter would affect only the 350˚ angle and no others.  With the exception of 30˚, 
the dosimeter’s response to these angles has never been reported, but Beyer et al. (2008) 
found the response at 30˚, 90˚ and 270˚ to be -0.6%, -3.6% and -6.0%, respectively.  
These values seem to be in agreement with this data, though 70˚ is already higher than 
the 90˚ measurement found by Beyer et al. (2008).  Again, however, the focus of this 
work is in the comparison of the commercial and modified dosimeter.  Based upon these 
 
Table 4 - Longitudinal Angular Dependence of both the Commercial and Modified 
Dosimeter 
 
Longitudinal Angle n Commercial Dosimeter Modified Dosimeter p-value
290 3 -4.85% -5.15% 0.819
310 3 -1.97% -2.63% 0.625
330 3 -1.73% -0.15% 0.305
350 3 -1.81% 1.55% 0.101
0 3 0.00% 0.00%
10 3 0.24% 0.74% 0.707
30 3 -1.96% -1.31% 0.630
50 3 -3.54% -1.72% 0.256
70 3 -5.31% -5.23% 0.951
Table 4 - Longitudinal Angular Dependence
53 
results, the modification of the dosimeter did not alter its longitudinal angular 
dependence. 
Azimuthal Angular Dependence 
 The angular dependence in the azimuthal direction for both the commercial and 
modified dosimeters is shown in Table 5.   
 
As mentioned in the Methods and Materials section, all data is relative to a 0˚ 
rotation, 0˚ longitudinal angle.  Since azimuthal angles are longitudinal angles at a 90˚ 
rotation, the azimuthal angle of 0˚ should roughly correspond to what was found for the 
90˚ angle in the rotational angular dependence study.  Upon analyzing this data, it seems 
that there is a systematic difference between the commercial and modified dosimeter 
with the commercial dosimeter reading roughly -5% and the modified dosimeter reading 
roughly -4%.  Therefore, the data are also presented as a difference from the azimuthal 
0˚ angle in Table 6.   
 
Table 5 - Azimuthal Angular Dependence of both the Commercial and Modified 
Dosimeters.  The data is reported relative to a 0˚ rotation, 0˚ longitudinal angle 
 
Azimuthal Angle n Commercial Dosimeter Modified Dosimeter p-value
290 3 -5.04% -4.63% 0.756
310 3 -5.88% -4.83% 0.459
330 3 -2.64% -4.43% 0.261
350 3 -4.81% -4.00% 0.556
0 3 -5.28% -4.21% 0.452
10 3 -5.33% -4.99% 0.796
30 3 -5.49% -4.51% 0.485
50 3 -5.41% -4.68% 0.592
70 3 -7.73% -6.43% 0.377
Table 5 - Azimuthal Angular Dependence Relative to Rotational 0
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 The azimuthal angular dependences of both the commercial and modified 
dosimeter are largely in agreement with the exception of the reading at 330˚ for which 
the commercial dosimeter read 2.64% (relative to the commercial dosimeter’s azimuthal 
0˚ reading) and the modified dosimeter read -0.22% (relative to the modified dosimeters’ 
azimuthal 0˚ reading).  This result is not statistically significant (p=0.132).  The values 
relative to the azimuthal 0˚ are all within ±1%, except for 70˚, which reads as roughly -
2% for both the commercial and modified dosimeters.  It is interesting that the azimuthal 
angular dependence is not similar to the longitudinal angular dependence, and is more a 
function of the rotational angular dependence than any other factor.  These results again 
show that the modification of the dosimeter did not alter the azimuthal angular 
dependence. 
  
 
Table 6 - Azimuthal Angular Dependence for both the Commercial and Modified 
Dosimeter.  Data presented is the difference between the angular readings and the 
Azimuthal 0˚ angular reading. 
 
Azimuthal Angle n Commercial Dosimeter Modified Dosimeter p-value
290 3 0.25% -0.42% 0.620
310 3 -0.59% -0.61% 0.988
330 3 2.64% -0.22% 0.132
350 3 0.48% 0.21% 0.837
0 3 0.00% 0.00%
10 3 -0.05% -0.78% 0.592
30 3 -0.21% -0.30% 0.945
50 3 -0.12% -0.47% 0.790
70 3 -2.44% -2.21% 0.861
Table 6 - Azimuthal Angular Dependence Relative to Azimuthal 0
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CONCLUSIONS 
Suitability of Modified Dosimeter as a Fiducial Marker  
 Based upon the imaging portion of this study, the modified dosimeter is visible 
on kV, MV and CBCT images.  Visibility is comparable to the gold marker in the MV 
images.  The modified dosimeter does have a disadvantage in terms of the artifacts 
produced in the CBCT images.  The artifacts produced by the modified dosimeter were 
larger than those produced by the commercially available dosimeter and by the gold 
marker.  These artifacts could be particularly problematic during initial CT simulation of 
the patient for treatment planning purposes.  Artifacts during CT simulation are an issue 
for all fiducial markers, however, and are certainly not limited to just the modified 
dosimeter.  It will be up to the physician to determine whether the detriments of 
additional artifacts from the modified dosimeter are worth the advantages of an in vivo 
dosimeter capable of being used for IGRT.  
Effect of Modification on Dosimeter Properties 
 The modified dosimeter showed no significantly different characteristics than the 
commercially available dosimeter.  The angles in the rotational, longitudinal and 
azimuthal direction were in surprisingly close agreement.  The difference between the 
energy dependence of the dosimeters was statistically significant, however the energy 
dependence of the dosimeters is dependent upon the manufacturing lot from which the 
MOSFETs came.  It seems more likely that the difference is explained by the fact that 
the modified dosimeters’ MOSFETs came from a different manufacturing lot than the 
commercial dosimeters than that the modification of the dosimeter had an effect on the 
energy dependence.  To test this assumption, dosimeters from the same MOSFET 
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manufacturing lot could be chosen and half modified, half left unmodified.  Ultimately, 
however, this test is irrelevant.  An energy dependence of -1.43%, as was found for the 
modified dosimeter will not have any effect on its usability as a dosimeter since energy 
dependences of ±1% are frequently found in the commercially available dosimeter.  
Therefore, even if the modification of the dosimeter were causing the energy 
dependence, its usability as a dosimeter would not be in jeopardy.  
Future Work 
 Future work could focus on altering the materials used in creating the fiducial 
marker to further improve its visibility.  Though it seems that the wire wrapped design is 
a good design to avoid hindering the wireless read range, a material other than gold 
could possibly be used.  The material would need to be sufficiently ductile to be shaped 
around the antenna.  Also, since Compton interactions dominate at MV level x-rays, the 
material need not be high-Z, but must have a high physical density.  A high density alloy 
might offer an even greater visibility at lesser cost than the gold.   
Recommendations  
 It is the opinion of this author that there is little reason not to incorporate this 
modification into the existing product.  Based upon this work, it seems likely that the 
modified dosimeter will provide all the advantages of an in vivo dosimeter that the 
original commercial dosimeter provided, while providing the benefit of an MV-visible 
fiducial marker for IGRT.   
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